LADENBURG THALM/SH SH Cuts Core Scientific (NASDAQ:CORZ) Price Target to $23.75

Core Scientific (NASDAQ:CORZ) had its price objective cut by equities researchers at LADENBURG THALM/SH SH from $24.50 to $23.75 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. LADENBURG THALM/SH SH’s price objective would indicate a potential upside of 52.24% from the company’s previous close.

Several other equities research analysts have also recently issued reports on the stock. Citigroup raised shares of Core Scientific from a “market perform” rating to an “outperform” rating in a research report on Thursday, December 18th. Zacks Research upgraded Core Scientific from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 13th. BTIG Research raised Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price objective for the company in a research report on Tuesday, January 6th. HC Wainwright reiterated a “buy” rating and issued a $25.00 price objective on shares of Core Scientific in a report on Tuesday. Finally, Keefe, Bruyette & Woods boosted their target price on Core Scientific from $19.00 to $25.00 and gave the stock a “moderate buy” rating in a research note on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.66.

Core Scientific Stock Performance

CORZ stock traded down $0.89 during mid-day trading on Tuesday, reaching $15.60. The company had a trading volume of 18,201,877 shares, compared to its average volume of 11,291,345. The firm has a fifty day simple moving average of $17.28 and a 200 day simple moving average of $16.96. The company has a market capitalization of $4.84 billion, a price-to-earnings ratio of 104.01 and a beta of 6.86. Core Scientific has a fifty-two week low of $6.20 and a fifty-two week high of $23.63.

Core Scientific (NASDAQ:CORZ) last released its earnings results on Monday, March 2nd. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.69. The firm had revenue of $79.76 million for the quarter, compared to analysts’ expectations of $118.45 million. The firm’s quarterly revenue was down 16.0% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.69) earnings per share. As a group, analysts predict that Core Scientific will post 0.52 earnings per share for the current year.

Institutional Investors Weigh In On Core Scientific

Several large investors have recently modified their holdings of the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Core Scientific by 2,631.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 46,987 shares of the company’s stock valued at $684,000 after acquiring an additional 45,267 shares in the last quarter. Alberta Investment Management Corp acquired a new stake in Core Scientific in the fourth quarter valued at about $1,820,000. Creek Drive Management Group LLC acquired a new stake in Core Scientific in the fourth quarter valued at about $1,638,000. Feynman Point Asset Management LLC purchased a new stake in Core Scientific in the 4th quarter valued at approximately $3,035,000. Finally, Galaxy Group Investments LLC acquired a new position in Core Scientific during the 4th quarter worth approximately $11,423,000.

Key Stories Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analysts reiterated/raised ratings and set bullish price targets that imply meaningful upside (Needham upgraded to Buy, PT $23; HC Wainwright reaffirmed Buy, PT $25; Cantor Fitzgerald keeps Overweight with a $25 PT). These signals can support buying interest. Benzinga Street Insider
• Positive Sentiment: Colocation revenue showed strong growth (reported surge ~268%), indicating traction in the shift to AI/colocation services — a structural growth driver that investors prize. Yahoo Finance
• Neutral Sentiment: Q4 results were mixed: management highlighted progress on scaling a 1.5 GW leasable colocation pipeline and execution on builds (positive for long-term revenue), but top-line metrics disappointed consensus. Company slides and the earnings presentation provide the details. Slide Deck Seeking Alpha
• Neutral Sentiment: Market narratives vary: some outlets emphasize a big long-term upside from the AI transition and large contracted revenue claims, which supports a bullish view but depends on execution and margin improvement. MarketBeat
• Negative Sentiment: Investors reacted to the top-line miss and capex/expansion cadence — the 1.5 GW buildout and continued scaling raise near-term cash burn and execution risk, prompting selling pressure. Blockonomi
• Negative Sentiment: Headline coverage framed the quarter as disappointing overall (revenue miss and mixed profitability metrics), which drove short-term downside despite some positive unit-metrics and analyst support. Blockonomi Zacks

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.